Redmile Group, LLC Shattuck Labs, Inc. Transaction History
Redmile Group, LLC
- $952 Million
- Q1 2025
A detailed history of Redmile Group, LLC transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 5,539,724 shares of STTK stock, worth $4.1 Million. This represents 0.55% of its overall portfolio holdings.
Number of Shares
5,539,724
Previous 5,539,724
-0.0%
Holding current value
$4.1 Million
Previous $6.7 Million
21.5%
% of portfolio
0.55%
Previous 0.52%
Shares
3 transactions
Others Institutions Holding STTK
# of Institutions
76Shares Held
30.9MCall Options Held
0Put Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$4.91 Million2.25% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$3.46 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$1.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.4MShares$1.78 Million0.0% of portfolio
-
Clark Estates Inc New York, NY1.48MShares$1.09 Million0.4% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $31.4M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...